Innovus Pharma Announces the Approval of the Product Licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® by the Indian FDA (Directorate General of Health Services) through its Partner Khandelwal Laboratories

SAN DIEGO (UPTICK Newswire - August 22nd, 2016) - Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB Venture Market: INNV), an emerging commercial stage cash flow positive pharmaceutical company that delivers safe, innovative…

Continue Reading
Close Menu